Skip to main content

Table 4 Non-haematological toxicity

From: A phase I trial of PR-104, a pre-prodrug of the bioreductive prodrug PR-104A, given weekly to solid tumour patients

Worst toxicity severity grade of non-haematological toxicity by patient (number of patients (%))

Toxicity severity grade

2

3

4

Fatigue

10 (38)

2 (8)

 

Abdominal pain

4 (15)

2 (8)

 

Constipation

7 (27)

  

Nausea

5 (19)

2 (8)

 

Back pain

3 (12)

2 (8)

 

Oedema peripheral

5 (19)

  

Vomiting

3 (12)

2 (8)

Â